Researcher
Eric Van Wijngaerden
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory for Clinical Infectious and Inflammatory Disorders (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 6 of 6
- Inferring HIV-1 epidemiological dynamics from next-generation sequencing dataFrom8 Sep 2017 → 8 Sep 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Hepatitis C virus direct acting antiviral (DAA) treatment success and its impact on transmission dynamics in HIV/HCV co-infected MSMFrom1 Jan 2017 → 31 Dec 2020Funding: FWO research project
- Novel insights in prevention and diagnosis of non-bacterial infections during critical illnessFrom1 Jun 2016 → 30 Sep 2020Funding: FWO fellowships
- Modeling and predicting HIV-1 transmission chains and therapy response.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project
- Fever in HIV-infected patientsFrom1 Feb 2010 → 26 Feb 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- Investigation of the clinical prognostic value for therapy, failure of HIV-1 drug resistance results combined with other clinical, virological and immunological parameters.From1 Jan 2009 → 31 Dec 2012Funding: FWO research project
Publications
1 - 10 of 91
- A Pathology-based Case Series of Influenza- and COVID-19-associated Pulmonary Aspergillosis(2023)
Authors: Simon Feys, Yves Debaveye, Greet Hermans, Stephanie Humblet-Baron, Katrien Lagrou, Laura Seldeslachts, Greetje Vande Velde, Eric Van Wijngaerden, Peter Alexander Wilmer, Eric Verbeken, et al.
Pages: 301 - 311 - Preclinical In Vitro Models of Vascular Graft Coating in the Prevention of Vascular Graft Infection: A Systematic Review (vol 63, pg 119, 2022)(2023)
Authors: Bart Meuris, Wilhelmus Metsemakers, Eric Van Wijngaerden, Inge Fourneau
Pages: 615 - 615 - Full-genome next-generation sequencing of hepatitis C virus to assess the accuracy of genotyping by the commercial assay LiPA and the prevalence of resistance-associated substitutions in a Belgian cohort(2022)
Authors: Kasper Thorhauge Christensen, Katrien Lagrou, Frederik Nevens, Anne-Mieke Vandamme, Eric Van Wijngaerden, Tim Dierckx, Lize Cuypers, Kristel Van Laethem
- Vascular Graft Infections With Candida: A Factor for Increased Mortality in in-situ Reconstructions(2022)
Authors: Hozan Mufty, Yves Debaveye, Eric Van Wijngaerden, Inge Fourneau
Pages: 206 - 211 - In situ Reconstruction with Autologous Veins for the Treatment of Infected Abdominal Endografts: Single Center Experience(2022)
Authors: Hozan Mufty, Eric Van Wijngaerden, Inge Fourneau
Pages: 150 - 154 - A public health value-based healthcare paradigm for HIV(2022)
Authors: Paul De Munter, Eric Van Wijngaerden
- Development of HIV Drug Resistance in a Cohort of Adults on First-Line Antiretroviral Therapy in Tanzania during the Stavudine Era(2021)
Authors: Eric Van Wijngaerden, Anne-Mieke Vandamme
Pages: 847 - 861 - Long-term safety and efficacy of rilpivirine in combination with nucleoside/nucleotide reverse transcriptase inhibitors in HIV-1 infected patients: 336-week rollover study of phase 2b and 3 clinical studies(2021)
Authors: Eric Van Wijngaerden
Pages: 95 - 105 - Pre-clinical In Vitro Models of Vascular Graft Coating in the Prevention of Vascular Graft Infection: A Systematic Review(2021)
Authors: Hozan Mufty, Bart Meuris, Wilhelmus Metsemakers, Eric Van Wijngaerden, Thomas Vandendriessche, Hans Steenackers, Inge Fourneau
Pages: 119 - 137 - Immunogenicity and Safety of the 9-Valent Human Papillomavirus Vaccine in Solid Organ Transplant Recipients and Adults Infected With Human Immunodeficiency Virus (HIV)(2021)
Authors: Lise Boey, Mathieu Roelants, Inge Derdelinckx, Eric Van Wijngaerden, Paul De Munter, Robin Vos, Dirk Kuypers, Johan Van Cleemput, Corinne Vandermeulen
Pages: E661 - E671